/ Unknown statusPhase 1/2 Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects
This trial is designed to study the effects of monthly transfusions of young healthy male donor plasma on biological age as assessed by DNA methylation levels, and changes in cognitive, renal, and pulmonary function, muscle strength, telomere length, testosterone, estrogen, DHEAS, IGF-1, high resolution C-Reactive protein, and expression of P16INK4a in peripheral blood T lymphocytes and skin biopsies.
100 Clinical Results associated with Fountain Labs, Inc.
0 Patents (Medical) associated with Fountain Labs, Inc.
100 Deals associated with Fountain Labs, Inc.
100 Translational Medicine associated with Fountain Labs, Inc.